1887

Journal of General Virology header logo

Volume 73, Issue 7

Activation of integrated human immunodeficiency virus type 1 in human neuroblastoma cells by the cytokines tumour necrosis factor alpha and interleukin-6 Free

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection was studied in two different human neuroblastoma cell lines, SK-N-MC and SH-SY5Y. Results from immunofluorescence analysis indicate that SK-N-MC cells express a 68K neurofilament, and SH-SY5Y cells express additionally a 160K to 200K neurofilament complex and thus represent a more differentiated state. HIV-1 infection in these cell lines was demonstrated by nested polymerase chain reaction and further characterized by hybridization, which showed that about 50% of SK-N-MC cells and 20% of SH-SY5Y cells were infected by HIV-1 and contained integrated proviral HIV-1 DNA. Among the cytokines and growth factors studied, tumour necrosis factor alpha (TNF-α) enhanced virus production in both cell lines, but to a differing extent, according to our mRNA and p24 antigen capture assay. In SK-N-MC cells the enhancement of HIV-1 mRNA was detected after 24 h of stimulation, and declined to the control level by 48 h. In SH-SY5Y cells a clear-cut stimulation was seen at both time points. By contrast, interleukin-6 (IL-6) enhanced the virus replication only in SK-N-MC cells, as shown at the mRNA level. Immunochemical staining showed no differences in the proportion of HIV-1-positive cells after 48 h of stimulation by TNF-α or IL-6 when compared to the control cells. In addition, based on a thymidine incorporation assay, TNF-α inhibited, but IL-6 strongly increased, the DNA synthesis in SK-N-MC cells, whereas in the SH-SY5Y cell line no such differences were seen. We discuss the possibility that developing, less-differentiated neurons may be more readily infected by HIV-1 than fully differentiated neurons, and that cytokines such as TNF-α and IL-6, which are elevated in HIV-1-infected individuals, may enhance HIV production.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1992
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-7-1753
1992-07-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/7/JV0730071753.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-7-1753&mimeType=html&fmt=ahah

References

  1. Ayehunie S., Johansson M., Salminen M., Leinikki P., Sönnerborg A., Zewdie D. W., Britton S., Stranneågrd Ö. 1991; HIV-1 in Ethiopia: phylogenetic difference from other HIV-1 strains. Virus Genes 5:359–366
     [Google Scholar]
  2. Biedler J. L., Helson L., Spengler B. A. 1973; Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Research 33:2643–2652
     [Google Scholar]
  3. Birx D. L., Redfield R. R., Tencer K., Fowler A., Burke D. S., Tosato G. 1990; Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76:2303–2310
     [Google Scholar]
  4. Breen E. C., Rezai A. R., Nakajima K., Beall G. N., Mitsuyasu R. T., Hirano T., Kishimoto T., Martinez-Maza O. 1990; Infection with HIV is associated with elevated IL-6 levels and production. Journal of Immunology 144:480–484
     [Google Scholar]
  5. Burns J., Graham A. K., Frank C., Fleming K. A., Evans M. F., McGee J. O. 1987; Detection of low copy human papillomavirus DNA and mRNA in routine paraffin sections of cervix by nonisotopic in situ hybridisation. Journal of Clinical Pathology 40:858–864
     [Google Scholar]
  6. Chiodi F., Fuerstenberg S., Gidlund M., Åsjö B., Fenyö E. M. 1987; Infection of brain-derived cells with the human immunodeficiency virus. Journal of Virology 61:1244–1247
     [Google Scholar]
  7. Clouse K. A., Powell D., Washington I., Poli G., Strebel K., Farrar W., Barstad P., Kovacs J., Fauci A. S., Folks T. M. 1989; Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. Journal of Immunology 142:431–438
     [Google Scholar]
  8. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., Macdonald S., Pulford K. A. F., Stein H., Mason D. Y. 1984; Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal of Histochemistry and Cytochemistry 32:219–229
     [Google Scholar]
  9. Cornblath D. R., McArthur J. C., Kennedy P. G. E., Witte A. S., Griffin J. W. 1987; Inflammatory demyelinating peripheral neuropathies associated with human T cell lymphotropic virus type III infection. Annals of Neurology 21:32–40
     [Google Scholar]
  10. Dahlen P. O., Iitia A. J., Skagius G., Frostell A., Nunn M. F., Kwiatkowski M. 1991; Detection of human immunodeficiency virus type 1 by using the polymerase chain reaction and a time-resolved fluorescence based hybridization assay. Journal of Clinical Microbiology 29:798–804
     [Google Scholar]
  11. Dewhurst S., Bresser J., Stevenson M., Sakai K., Evinger-Hodges M. J., Volsky D. J. 1987; Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV). FEBS Letters 213:138–143
     [Google Scholar]
  12. Dickson D. W., Mattiace L. A., Kure K-., Hutchins K., Lyman W. D., Brosnan C. F. 1991; Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Laboratory Investigation 64:135–156
     [Google Scholar]
  13. Epstein L. G., Sharer L. R., Cho E.-S., Mayenhofer M., Navia B. A., Price R. W. 1984–1985; HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Research 1:447–454
     [Google Scholar]
  14. Epstein L. G., Sharer L. R., Goudsmit J. 1988; Neurological and neuropathological features of human immunodeficiency virus infection in children. Annals of Neurology 23:19–23
     [Google Scholar]
  15. Folks T. M., Clouse K. A., Justement J., Rabson A., Duh E., Kehrl J. H., Fauci A. S. 1989; Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T cell clone. Proceedings of the National Academy of Sciences, U.S.A. 86:2365–2368
     [Google Scholar]
  16. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. 1987; Antigen presentation and tumor cytotoxicity by interferon-gamma treated microglial cells. European Journal of Immunology 17:1271–1278
     [Google Scholar]
  17. Frei K., Malipiero U. V., Leist T. P., Zinkernagel R. M., Schwab M., Fontana A. 1989; On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. European Journal of Immunology 19:689–694
     [Google Scholar]
  18. Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., Fontana A. 1989; Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. Journal of Neuroimmunology 23:109–116
     [Google Scholar]
  19. Grimaldi L. M. E., Martino G. V., Franciotta D. M., Brustia R., Castagna A., Pristera R., Lazzarin A. 1991; Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Annals of Neurology 29:21–25
     [Google Scholar]
  20. Harouse J. M., Kunsch C., Hartle H. T., Laughlin M. A., Hoxie J. A., Wigdahl B., Gonzales-Scarano F. 1989; CD4-independent infection of human neural cells by human immunodeficiency virus type 1. Journal of Virology 63:2527–2533
     [Google Scholar]
  21. Higuchi R. 1989; Amplifications. News Letter, Perkin-Elmer/Cetus 2:1–3
     [Google Scholar]
  22. Ho D. D., Rota T. R., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J. E., Resnick L., Felsenstein D., Andrews C. A., Hirsch M. S. 1985; Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. New England Journal of Medicine 313:1493–1497
     [Google Scholar]
  23. Johnson R. T., McArthur J. C., Narayan O. 1988; The neurobiology of human immunodeficiency virus infections. FASEB Journal 2:2970–2981
     [Google Scholar]
  24. Koyanagi Y., Miles S., Mitsuyasu R. T., Merril J. E., Vinters H. V., Chen I. S. Y. 1987; Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819–822
     [Google Scholar]
  25. Lähdevirta J., Maury C. P. J., Teppo A.-M., Repo H. 1988; Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. American Journal of Medicine 85:289–291
     [Google Scholar]
  26. Laurenzi M. A., Siden Persson M. A. A., Norkrans G., Hagberg L., Chioidi F. 1990; Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clinical Immunology and Immunopathology 57:233–241
     [Google Scholar]
  27. Li X. L., Moudgil T., Vinters H. V., Ho D. D. 1990; CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. Journal of Virology 64:1383–1387
     [Google Scholar]
  28. McArthur J. C. 1987; Neurologic manifestations of AIDS. Medicine 66:407–437
     [Google Scholar]
  29. Merrill J. E., Chen I. S. Y. 1991; HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB Journal 5:2391–2397
     [Google Scholar]
  30. Nakajima K., Martinez-Maza O., Hirano T., Breen E. C., Nishanian P. G., Salazar-Gonzales J. F., Fahey J. L., Kishimoto T. 1989; Induction of IL-6 (B cell stimulatory factor-2/IFNβ 2) production by HIV. Journal of Immunology 142:531–536
     [Google Scholar]
  31. Påhlman S., Odelstad L., Larsson E., Grotte G., Nilsson K. 1981; Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. International Journal of Cancer 28:583–589
     [Google Scholar]
  32. Pinkel D., Straume T., Gray J. 1986; Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proceeding of the National Academy of Sciences, U.S.A. 83:2934–2938
     [Google Scholar]
  33. Poli G., Kinter A., Justement J. S., Kehrl J. H., Bressler P., Stanley S., Fauci A. S. 1990a; Tumor necrosis factor a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proceedings of the National Academy of Sciences, U.S.A. 87:782–785
     [Google Scholar]
  34. Poli G., Bressler P., Kinter A., Duh E., Timmer W. C., Rabson A., Justement J. S., Stanley S., Fauci A. S. 1990b; Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. Journal of Experimental Medicine 172:151–158
     [Google Scholar]
  35. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. 1988; The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586–592
     [Google Scholar]
  36. Rieckmann P., Poli G., Kehrl J. H., Fauci A. S. 1991; Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, Ul. Journal of Experimental Medicine 173:1–5
     [Google Scholar]
  37. Robbins D. S., Shirazi Y., Drysdale B.-E., Liebermann A., Shin H. S., Shin M. L. 1987; Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. Journal of Immunology 139:2593–2597
     [Google Scholar]
  38. Salminen M. 1992; Rapid and simple characterization of in vivo HIV-1 sequences using solid phase directed sequencing. AIDS Research and Human Retroviruses (in press)
    [Google Scholar]
  39. Seibl R., Höltke H.-J., Ruger R., Meindl A., Zachau H. G., Rasshofer R., Roggendorf M., Wolf H., Arnold N., Wienberg J., Kessler C. 1990; Non-radioactive labeling and detection of nucleic acids. III. Applications of the digoxigenin system. Biological Chemistry Hoppe-Seyler 371:939–951
     [Google Scholar]
  40. Selmaj K. W., Raine C. S. 1988; Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Annals of Neurology 23:339–346
     [Google Scholar]
  41. Sharer L. R., Epstein L. G., Cho E.-S., Joshi V. V., Meyenhofer M. F., Rankin L. F., Petito C. K. 1986; Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Human Pathology 17:271–284
     [Google Scholar]
  42. Stoler M. H., Eskin T. A., Benn S., Angerer R. C., Angerer L. M. 1986; Human T-cell lymphotropic virus type III infection of the central nervous system: a preliminary in situ analysis. Journal of the American Medical Association 256:2360–2364
     [Google Scholar]
  43. Vazeux R., Brousse N., Jarry A., Henin D., Marche C., Vedrenne C., Mikol J., Wolff M., Michon C., Rozenbaum W., Bureau J.-F., Montagnier L., Brahic M. 1987; AIDS subacute encephalitis: identification of HIV-infected cells. American Journal of Pathology 126:403–410
     [Google Scholar]
  44. Vesanen M., Linna T., Vaheri A. 1991; Persistent inapparent HIV-1 infection of human neuroblastoma cells. Archives of Virology 120:253–261
     [Google Scholar]
  45. Watkins B. A., Dorn H. H., Kelly W. B., Amstrong R. C., Potts B. J., Michaels F., Kufta C. F., Dubois-Dalcq M. 1990; Specific tropism of HIV-1 microglial cells in primary human brain cultures. Science 249:549–553
     [Google Scholar]
  46. Wigdahl B., Kunsch C. 1990; Human immunodeficiency virus infection and neurologic dysfunction. Progress in Medical Virology 37:1–46
     [Google Scholar]
  47. Wiley C. A., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone B. A. 1986; Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences, U.S.A. 837089–7093
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-7-1753
Loading
Activation of integrated human immunodeficiency virus type 1 in human neuroblastoma cells by the cytokines tumour necrosis factor alpha and interleukin-6
J. Gen. Virol. 73, 1753 (1992); https://doi.org/10.1099/0022-1317-73-7-1753
/content/journal/jgv/10.1099/0022-1317-73-7-1753
/content/journal/jgv/10.1099/0022-1317-73-7-1753
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error